Point-of-care testing for nasogastric tube placement verification in neonates and children

新生儿和儿童鼻胃管放置验证的护理点测试

• 批准号: 700652
• 金额: $ 3.19万
• 依托单位: INGENZA LIMITED
• 依托单位国家: 英国
• 项目类别: GRD Proof of Market
• 财政年份: 2016
• 资助国家: 英国
• 起止时间: 2016 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=700652
• 关键词: Point; care; testing; nasogastric; tube

Nasogastric (NG) tube feeding is common practice in hospitalised children and neonates tofacilitate nutrient intake and medication administration. However, tube misplacement is notuncommon and is a significant issue as a tube misplaced into the lungs instead of the stomachcan be fatal. This has led the NHS to recently classify NG tube misplacement as a ‘neverevent’. Children and neonates are at increased risk of misplacement compared with adultsbecause of their age, increased activity and non-purposeful movement of limbs or the headand neck. ). To address misplacement issues, Ingenza have devised a novel, easy to use, lowcost point-of-care (PoC) test for confirmation of the safe placement of NG tubes in neonatesand children. An easy and reliable PoC test will allow ongoing verification of the location ofthe device and its tip with accuracy. It will reduce harm occurring to children and neonate inNG tube feeding. It will reduce exposure to X-ray radiation and avoid delays in initiating andadvancing enteral nutrition.

鼻胃管喂养是住院儿童和新生儿的常见做法，以促进营养摄入和药物管理。然而，管错位并不罕见，是一个重要的问题，因为管错位到肺部而不是胃可能是致命的。这导致NHS最近将NG管错位归类为“永不发生”。与成人相比，儿童和新生儿的错位风险增加，因为他们的年龄，活动增加和四肢或头部和颈部的无目的运动。).为了解决错位问题，Ingenza设计了一种新颖的、易于使用的、低成本的床旁（Point-of-Care）检测，用于确认NG管在孕妇和儿童中的安全放置。一个简单可靠的测试将允许不断验证的位置ofthe设备及其尖端的准确性。减少NG管饲对儿童及新生儿的危害。它将减少暴露于X射线辐射，并避免延迟启动和推进肠内营养。